Bank of Montreal’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-149
| Closed | -$29K | – | 4451 |
|
2021
Q1 | $29K | Sell |
149
-228
| -60% | -$44.4K | ﹤0.01% | 3527 |
|
2020
Q4 | $74K | Buy |
377
+205
| +119% | +$40.2K | ﹤0.01% | 3283 |
|
2020
Q3 | $33K | Sell |
172
-44
| -20% | -$8.44K | ﹤0.01% | 3201 |
|
2020
Q2 | $48K | Buy |
216
+148
| +218% | +$32.9K | ﹤0.01% | 3101 |
|
2020
Q1 | $7K | Sell |
68
-133
| -66% | -$13.7K | ﹤0.01% | 3299 |
|
2019
Q4 | $38K | Buy |
201
+42
| +26% | +$7.94K | ﹤0.01% | 3458 |
|
2019
Q3 | $31K | Sell |
159
-111
| -41% | -$21.6K | ﹤0.01% | 3361 |
|
2019
Q2 | $47K | Buy |
270
+145
| +116% | +$25.2K | ﹤0.01% | 3270 |
|
2019
Q1 | $25K | Sell |
125
-7
| -5% | -$1.4K | ﹤0.01% | 3192 |
|
2018
Q4 | $25K | Sell |
132
-77
| -37% | -$14.6K | ﹤0.01% | 3219 |
|
2018
Q3 | $50K | Buy |
209
+82
| +65% | +$19.6K | ﹤0.01% | 3082 |
|
2018
Q2 | $33K | Sell |
127
-110
| -46% | -$28.6K | ﹤0.01% | 3254 |
|
2018
Q1 | $59K | Buy |
237
+117
| +98% | +$29.1K | ﹤0.01% | 2909 |
|
2017
Q4 | $16K | Buy |
120
+119
| +11,900% | +$15.9K | ﹤0.01% | 3329 |
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3942 |
|
2017
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3887 |
|
2017
Q1 | – | Sell |
-1
| Closed | – | – | 3795 |
|
2016
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3809 |
|